Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Daiichi reports calmodulin inhibitors

Oct. 25, 1996

SCRAS claims NOS inhibitors

Oct. 25, 1996

Glaxo Wellcome claims NMDA antagonists

Oct. 25, 1996

Twenty-four drugs in development for Alzheimer's disease in U.S.

Oct. 25, 1996

Two Alzheimer's drugs in phase III in Japan

Oct. 25, 1996

Spotlight on ALS research

Oct. 25, 1996

Cephalosporin tested in Italian patients with ALS

Oct. 25, 1996

Talipexole now available in Japan

Oct. 25, 1996

Neuroprotective calpain inhibitors from Warner-Lambert

Oct. 18, 1996

Huperzine A analogues claimed for treatment of AD

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.